A
Amfora
Harnessing biology to sustainably nourish the planet and enhance global wellness
About Amfora
Amfora is an agricultural company dedicated to human and animal nutrition through innovative biotechnology. Operating in the plant-based protein market, Amfora leverages its patented gene editing technology to develop plant-based replacements for animal proteins and increase the protein content of staple food crops. This approach addresses growing consumer concerns about health and environmental sustainability. Amfora's business model focuses on research and development, partnering with investors who are interested in sustainable agriculture and food security. The company generates revenue through the commercialization of its biotechnology solutions and partnerships with food producers and agricultural firms.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- San Francisco, United States
- Sector
- Food
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Spruce Capital Partners
CSIRO
Leaps by Bayer
BayWa
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Amfora on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Amfora on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.